Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.

Authors	Kacey O'Rourke, Kirk Morris, Glen A Kennedy
Journal	Cancer (Cancer) Vol. 117 Issue 11 Pg. 2579-80; author reply 2580-1 (Jun 01 2011) ISSN: 1097-0142 [Electronic] United States
PMID	24048807 (Publication Type: Letter, Comment)
Chemical References	Methotrexate
Topics	Central Nervous System Neoplasms (prevention & control, secondary) Female Humans Lymphoma, Large B-Cell, Diffuse (drug therapy) Male Methotrexate (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!